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Summary The incidence of colorectal carcinoma is rising at an alarming pace in Asian urban societies such as Hong Kong. Detailed
examination of the epidemiological pattern and genetic mutation of colorectal cancer in the Hong Kong Chinese population is overdue. We
compared the reported age incidence of colorectal carcinoma in Hong Kong with that of Scotland and other countries. Hong Kong showed a
much higher incidence of colorectal carcinoma among the young age groups. By comparison with other countries, this raised incidence
among the young appeared to be related to southern Chinese societies. The recent dramatic rise in colorectal cancer in Hong Kong was
largely attributable to an increase in the over 50 years age group, while the young incidence remained unchanged. We also defined the
mutation spectrum of p53and Ki-ras in 67 unselected cases by direct DNA sequencing. Interestingly, insertion/deletion mutations in p53from
colorectal carcinoma in Hong Kong showed a significantly higher frequency (17.2%) than the Scottish data (0%) and the world database
(6.6%), although the overall frequency of p53mutation (43%) in Hong Kong was similar to others. The high incidence of colorectal carcinoma
in young people and the raised proportion of frameshift mutations in p53encourage further search for a genetic basis for susceptibility to this
disease in the Hong Kong Chinese population.
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The incidence of colorectal carcinoma varies greatly throughout
the world. In general, itis high in the Western developed countries,
low in developing countries and intermediate but rising rapidly in
urban societies of eastern Asia, such as Japan, Singapore and
Hong Kong. There is long accepted evidence to support the view
that these differences reflectenvironmental -presumably dietary -
carcinogenic factors. For example, classical studies in the 1960s
on Japanese immigrants to Hawaii (Haenszel and Kurihara, 1968)
and Polish immigrants to the USA (Staszewski and Haenszel,
1965) showed that, with time, but within a single generation in the
new location, such immigrants slowly adopted a higher colorectal
cancer risk approaching that of their new environment. In Hong
Kong colorectal carcinoma is now the second most common
cancer and the third most common cause of cancer death (Hong
Kong Government, 1982-95; Hong Kong Cancer Registry, 1995).
The age standardized incidence rate in 1991 was 35.4:100 000 for
men and 28.5:100 000 for women (Hong Kong Cancer Registry,
1995). More than 95% of the population are ethnic Chinese and,
although there have doubtless been many changes in the past few
decades, the majority have a life style and diet still greatly
different to those ofthe West.
Genetic changes are also very significant in colorectal carcino-
genesis. Most tumours have acquired (non-germline) inactivating
mutations in adenomatous polyposis coli (APC) (Ashton Rickardt
et al, 1989; Nishisho et al, 1991; Powell et al, 1992); activating
mutations in the Ki-ras oncogene are present in about 40% of
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carcinomas (Bos et al, 1987; Forrester et al, 1987); and mutations
in thep53 and 'deleted in colon carcinoma' (DCC) oncosuppressor
genes are found in 70-80% of carcinomas (Vogelstein et al, 1988;
Baker et al, 1989; Vogelstein et al, 1989; Baker et al, 1990; Fearon
et al, 1990; Hollsetein et al, 1991). Moreover, although most
cancers arise in patients over the age of 50 years, some are diag-
nosed substantially earlier, and in such younger patients there is
often evidence for inherited susceptibility to the disease. One
example of this is the hereditary non-polyposis colon cancer
(HNPCC) syndrome, in which there is inherited deficiency of one
of the nucleotide mismatch repair genes, and this deficiency is
expressed with high penetrance in kindreds showing a mendelian
dominant pattern of inherited susceptibility to colorectal cancer.
However, recent examination of atypically young patients with
colorectal cancer,' even those with no known family history, has
revealed a proportion of individuals with germline mutation in
mismatch repair genes that may be as high as 42% (Liu et al,
1995). Mutations apparently driven by the defective mismatch
repair are found in classical colorectal cancer genes, such as APC,
and have a characteristic signature, with a predominance of
nucleotide deletions or insertions within simple repeat sequences -
unlike thetransversion type ofpointmutations that characterize the
interactions of many environmental carcinogens with DNA
(Huang et al, 1996). Hence, detailed study ofthe age incidence and
the mutational spectra in colorectal cancer may shed light not only
on differences in environmental carcinogens but also on the rela-
tive importance ofgenetic susceptibility in different populations.
Here, we report the unusual age-incidence pattern ofcolorectal
cancer in Hong Kong. As expected, we show the dramatic rise
in incidence of disease in the over 50 years age group within the
past 10-20 years. However, we also demonstrate features sugges-
tive ofthe presence of a susceptibility gene within the Hong Kong
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population - a relatively high incidence in young people and a
raised proportion of frameshift mutations in the p53 oncosup-
pressor gene in comparison with Caucasian populations. Evidence
is also presented that this may be a southem Chinese characteristic,
distinct from the factors responsible forthe rising overall incidence
ofcolorectal cancer in urbanized south east Asian populations.
MATERIALS AND METHODS
Analysis of epidemiology data
Data on cancers of colon and rectum from the cancer registries
from Hong Kong and Scotland recorded in the WHO Cancer
Incidence in Five Continents 1978-82 (Muir et al, 1987) and
1983-87 (Parkin et al, 1992) were analysed. Data from Hong
Kong Govemment statistics (Hong Kong Government, 1982-95;
Hong Kong Cancer Registry, 1995) and Scottish health statistics
for 1989 were also analysed and compared in detail. Finally, we
also sought pathological data from the Hong Kong Cancer
Registry concerning the nature ofthe cancers ofcolon and rectum.
For all the cases in the Registry, a diagnosis of colorectal cancer
was given and, for 80% of these cases, a histopathological report
was available for confirmation.
The population-based Cancer Registry in Hong Kong has been
operating since 1963. The majority ofthe data were from oncology
and pathology departments of all government-funded and private
hospitals, and the rest came from discharge summaries of all
public and private hospitals and death certificates, in which the
cause of death was a compulsory recording by accredited medical
practitioners. Duplicate registration was eliminated by checking
the demographic data in which the Identity Card number is unique
for every individual in Hong Kong. The registration data in
Scotland were mainly derived from hospital in-patient sources and
a small proportion came from out-patient departments, and death
certificates.
Analysis of Ki-ras and p53 mutations
Tissue andDNA extraction
Sixty-seven unselected colectomy specimens with diagnosis of
adenocarcinoma received in Queen Mary Hospital in the year
1990-91 were studied. Thirty-six were from male and 31 from
female Chinese patients. The patients' age ranged from 24-88
years, with 13% aged below 40 years. The specimens were
received unfixed on ice from the operating theatre, and representa-
tive blocks were taken from both the tumour and the normal
mucosa, snap frozen in liquid nitrogen and stored at -70°C. The
rest of the specimens were fixed in 10% buffered formalin and
processed through paraffin for histology.
Frozen sections, prepared from the stored frozen blocks, were
assessed under light microscope. DNA was extracted by
proteinase K digestion, phenol-chloroform extraction and ethanol
precipitation. Only blocks with tumour occupying more than 70%
of section area were used. At the same time, DNA was also
extracted from normal mucosa.
p53 mutations
Immunohistochemical studies were performed using monoclonal
antibodies PAb 1801 and PAb 240 (Oncogene Science) and poly-
clonal antibody CM1 (Novocastra), using either frozen (PAb 240
only) or paraffin sections, the latter fixed in formalin or PLPD,
using a standard ABC technique with and without microwave pre-
treatment (Purdie et al, 1991; Cripps et al, 1994).
Mutations within exons 4-10 were screened by polymerase
chain reaction-single-strand conformation polymorphism (PCR-
SSCP)as previously described (Orita et al, 1989; Suzuki et al,
1990; Cripps et al, 1994). The primers used were as follows: exon
4: 5'-TTCACCCATCTACAGTCC-3' and 5'-CTCAGGGCA-
ACTGACCGT-3'; exon 5: 5'-TTCCTCTTCCTGCAGTACTC-3'
and 5'-ACCCTGGGCAACCAGCCCTGT-3'; exon 6: 5'-
ACAGGGCTGGTTGCCCAGGGT-3' and 5'-AGTTGCAAACC-
AGACCTCAG-3'; exon 7: 5'-GTGTTGTCTCCTAGGTTGGC-3'
and 5'-GTCAGAGGCAAGCAGAGGCT-3'; exon 8: 5'-TATCCT-
GAGTAGTGGTAATC-3' and 5'-AAGTGAATCTGAGGCAT-
AAC-3'; exon 9: 5'-GCAGTTATGCCTCAGATTCAC-3' and
5'-AAGACTTAGTACCTGAAGGGT-3'; and exon 10: 5'-
CTCTGTTGCTGCAGATCC-3' and 5'-GCTGAGGTCACT-
CACCTGGA-3'.
The polymerase chain reactions (PCR) were performed on
0.5 ,ug of DNA samples, in a 50-,ul reaction containing 200 gM of
each deoxynucleotide, 0.5 jiCi[32P]dCTP, 0.33 gM of each primer
and 1 unit of Taq polymerase in appropriate buffer. PCRs were
performed in a DNA thermocycler (Perkin Elmer) with the
following temperature profile: 94°C for 4 min then 30 cycles of
94°C for40 s, 58-63'C (depending on primers) for40 s, and 72°C
for 1 min, then 72°C for 10 min. Of the PCR products, 7 gl was
mixed with 5 ,l of sequencing stop solution, heated to 80°C for 2
min and 5 p1 was loaded onto a 5% glycerol-6% polyacrylamide
gel. The gels were run at room temperature, 3 W for 12-15 h in
vertical polyacrylamide gel apparatus (Hoefer). The gel was fixed,
dried and then exposed to radiographic films.
Three ofthe mutation 'hot spots' inp53 form part ofthe recog-
nition sequence of known restriction endonucleases: codon 248
(exon 7) and 282 (exon 8) form part ofMsp I site and codon 175
(exon 5) form part of Hae II site. Hence, we used a rapid non-
radioactive PCR-based method to screen for mutations in these
codons. Two PCR fragments were used: one spanning exon 7-8,
while the othercovered only exon 5. These were digestedusing the
appropriate restriction enzymes, and the resulting fragments were
analysed by ethidium bromide-stained 2% agarose gel.
Direct DNA sequencing was performed on single-stranded
DNA templates generated by asymmetric PCR using either excess
5' or 3' primers (Gyllensten and Erlich, 1988). Both DNA strands
of the PCR products were sequenced using the chain termination
method with [35S]dATP following the manufacturer's protocols
(Pharmacia). The samples were denatured at 80°C for 5 min and
electrophoresed through a 6% polyacrylamide-urea gel. After
electrophoresis, the gel was fixed, dried and exposed to auto-
radiographic film.
Ki-ras mutations
For detection of mutations in Ki-ras codons 12 and 13, similar
methods were used as described above for the detection of p53
mutations. The primers used were as follows: 5'-ACTGA-
ATATAAACTTGTGGTAGTTGGACCT-3' and 5'-TCAAAGA-
ATGGTCCTGGACC-3'. The PCRs were performed on 0.25 jig of
DNA, in a 50-jil solution containing 0.2gM dNTPs, 0.3 jM of
each primer and one unit of Taq DNA polymerase. The reactions
were performed in a DNA thermocycler (Perkin Elmer) with the
following temperature profile: 940C for 3 min, then 30 cycles of
94°C for 1 min, 55°C for 1.5 min and 72°C for 2 min, followed by
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Figure 1 (A) Male incidence of colorectal cancer in various age groups in
Hong Kong and Scotland in 1978-82 and 1983-87. The female incidence
patterns are similar. (B) Comparison of the male incidence of colorectal
cancer in Hong Kong, Japan (Osaka), Scotland and USA (white) in the period
1983-87. Similar incidence patterns are also observed in the female
population
final extension at 72iC for 10 mi. Single-stranded DNA was
generated by asymmetric PCR and sequenced using the chain
termination method.
RESULTS
Epidemiology
Throughout the two study periods of 1978-82 and 1983-87, the
total populations of Hong Kong and Scotland were similar. In the
period 1978-82, Hong Kong had a population of 5 038 500 (male,
2 626 500; female, 2412 000), while Scotland had a population of
5 180 200 (male, 2494 860; female, 2685 340). In 1983-87, the
total population in Hong Kong was 5469 040 (male, 2 822 840;
female, 2 646 200), while in Scotland it was 5 133 138 (male,
2478 922; female, 2 654 216). The overall age-standardized inci-
dence rates (ASR) of colorectal carcinoma in Hong Kong were
28.2 (male) and 21.7 (female) in the period 1978-82 and 34.5
(male) and 26.0 (female) in 1983-87. The corresponding ASR in
Scotland were 33.7 (male) and 27.1 (female) in the first period and
35.2 (male) and 26.7 (female) in the latter period. Thus, within the
period 1978-82, the overall ASR of colorectal cancer in Hong
Kong was lower than that ofScotland. However, there was a great
difference between Hong Kong and Scotland in the distribution of
colorectal cancer in the various age groups (Figure IA). From the
age of 20 years through to 50 years, Hong Kong had a higher inci-
dence of colorectal cancer compared with the same age group in
Scotland. The same higher incidence of colorectal cancers in the
young Hong Kong Chinese population remained unchanged in the
period 1983-87. Indeed, in Hong Kong in 1987, there were almost
fourtimes more new colorectal cancer cases perhead ofpopulation
in the 15-35 years age group than in Scotland (3.1 vs 0.81 per 105;
P =0.000005 using Chi-squared test onexact number ofnew cases
and the age group population in that year). In this second period,
however, Hong Kong demonstrated a substantial increase in the
overall incidence ofcolorectal cancers, attributable almost entirely
to increased incidence in the population aged 50 years or above. In
Scotland, there was little change in the age-incidence pattern
between the two study periods. A similar pattern was also observed
in analysing the most recent available data for 1990 and 1991.
The exact pathology or ICD coding of these patients in the
second study period, i.e. 1983-87, were sought from the Hong
Kong Cancer Registry. There were 573 cases with a diagnosis of
colorectal cancer in those under the age of40 years. Only 16 cases
(2.78%) had diagnoses of malignancies not related to adenocarci-
noma. These included malignant melanoma, malignant teratoma,
leiomyosarcoma, squamous carcinoma and basaloid carcinoma.
The remainder were listed as either adenocarcinoma or related
malignancies, such as mucinous adenocarcinoma or signet ring
cell carcinoma.
We next investigated whether this higher incidence ofcolorectal
cancer in the young Hong Kong population was a feature ofother
eastern Asian populations showing rising overall incidence of the
disease. Accordingly, we compared the incidence of colorectal
cancer in the younger age groups of several populations, some of
southern Chinese extraction, some showing the Eastern Asian
recent rise in incidence and others with different features (Table 1).
Hong Kong, Singapore (Chinese) and Shanghai - all with popula-
tions of predominantly southern Chinese ethnic background - all
shared the relatively high incidence of colorectal cancer in
younger age groups, although only in Hong Kong and Singapore
was there a large rise in incidence in older age groups between
1978-82 and 1983-87. In contrast, Tianjin, a northern Chinese
city, had low incidence in young people. Japan (Osaka) also had
low incidence in young people, although it shared the recent rising
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Table 1 Comparison for different countries/cities of the incidence of colorectal carcinoma (CRC) in young age groups (20-40 years) and the overall world age-
standardized rate (ASR) in the period 1983-87, and the percentage increase in overall world ASR in this period compared with 1978-82 (Muir et al, 1987;
Parkin et al, 1992)
Countries Annual CRC incidence ASR (1983-87) Percentage increase in ASR Percentage increase in ASR
rate (1983-87) Male/Female 1983-87 vs 1978-82 (M) 1983-87 vs 1978-82 (F)
Hong Kong 5.23 34.5/26.0 22 20
Singapore 4.02 35.4/28.6 14.2 8
China 4.46 17.8/15.6 0 6
Shanghai
China 2.46 9.6/9.2 NA NA
Tianjin
Japan (Osaka) 2.99 26.4/16.4 16.3 14
Scotland 2.56 35.2/26.7 4.5 -1.5
USA (white) 2.39 46.5/33.2 NA NA
Table 2 Ki-ras mutations in colorectal carcinomas in Hong Kong and
Scotland
DNA mutation Amino acid change No. of cases No. of cases
(Hong Kong) (Scotland)
codon 12 GGT- GAT Gly - Asp 10 18
codon 12 GGT-- GTT Gly - Val 8 5
codon 12 GGT- AGT Gly - Ser 1 3
codon 12 GGT--* GCT Gly - Ala 1 4
codon 13 GGC - GAC Gly - Asp 1 2
trend in older ages with Hong Kong and Singapore. USA (white)
had a similar pattern to that of Scotland: a low incidence in young
people and a static high incidence in the older age groups. These
differences in the incidence of colorectal cancer in various age
groups between Hong Kong, Japan (Osaka), Scotland and USA
(white) in the period 1983-87 are shown in Figure lB.
Ki-ras mutations
Analysis of Ki-ras mutations using PCR and DNA sequencing
identified 21 mutations (29.4%) in the 67 cases studied. Of these,
20 were at codon 12 and only one atcodon 13. Twelve were G-*A
transitions, eight G-4T transversions and one was a G-*C trans-
version. The incidence and spectrum of the mutations are not
significantly different to that obtained by the same methods in
Scotland. The nature ofthe DNA mutations and the corresponding
amino acid change are indicated in Table 2.
p53 mutations
With immunohistochemical studies, there were 32 (47.1%) cases
stained positive for p53 protein, a figure almost identical to that
obtained by similar methods in Scotland (Purdie et al, 1991). All
these cases showed strong nuclear staining in the majority of the
tumour cells. The use of microwave for antigen retrieval would
add afurtherthree positive cases that would otherwise be negative.
The various p53 antibodies, namely PAb2 and PAb3 and the poly-
clonal CM1, showed similar staining patterns.
Analysis by polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP), SSCP and direct DNA
sequencing identified 29 mutations in the 67 cases studied. Details
ofthep53 mutations are summarized in Table 3. All 29 mutations
were identified within exons 5-8. No mutation was found in exon
4, 9 and 10. Of the 29 mutations, 19 were either C-*T or GeA
transitions and 16 of these occurred at CpG dinucleotides.
Frequent mutations were found in four (codons 175, 245, 248 and
282) of the five mutation hotspots of p53, but none in the
remaining hot spot at codon 273. In addition, a total of five dele-
tions/insertions were identified. SSCP identified 28 of the 29
mutations in the present series. The remaining case had a missense
mutation at codon 245 (GGC->GAC) identified by PCR-RFLP.
All cases with missense mutations showed positive immunohis-
tochemical staining, while all those cases with truncated proteins
as a result offrameshift or non-sense mutations showed a negative
immunostaining result. Without microwave pretreatment, seven
cases had stabilized nuclear p53 protein by positive immuno-
staining but no p53 mutations. In addition, p53 mutation was not
found in the three cases that showed positive p53 staining only
after microwave treatment.
Using the same methods, very similar results were obtained in
the Scottish population, except that this contained no insertion or
deletion mutation (Cripps et al, 1994).
We further compared our results with a large international data-
base of p53 mutations (a total of 3720) from various tumours
(Hollstein et al, 1994); 376 were p53 mutations in colorectal
tumours and, ofthese, 25 tumours haddeletion/insertion mutations
constituting 6.6%. This is lower than the 17.2% (5/29) deletion/
insertion mutations in our present Chinese series (P = 0.036 using
Chi-squared test).
DISCUSSION
The data reveal two outstanding features of the epidemiology of
colorectal cancer in Hong Kong. First, there are striking differ-
ences between the two study periods 1978-82 and 1983-87; the
age-standardized incidence rate rose nearly 20% in women and
over 22% in men. This rate of increase, approximately 4% per
year, is entirely attributable to classical, late-onset (>50 years old)
patients. The age-incidence dataforScotland, in contrast, show no
change over the same period, although demonstrating a higher
overall incidence. Secondly, there is an excess ofpatients, by up to
fourfold, in the younger age groups in Hong Kong as compared
with Scotland. As colorectal cancer in this young age group in
Scotland has been shown to be associated with constitutional
defects in DNA repair (Liu et al, 1995), this observation prompted
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Table 3 p53mutation in colorectal carcinoma in Hong Kong
Exon DNA mutation Amino acid/Protein change IHC SSCP Sex/Age (years)
5 Codon 138 GCC-*GCCC Frame shift-truncated protein (147 a.a.) - + M/42
(1-bp insertion)
5 Codon 145 CTG-*CCG Leu-*Pro + + M/24
5 Codon 158 CGC-+CAC Arg->His + + M/70
5 Codon 168 CAC-*CM His-*Gln + + M/65
5 Codon 175 CGC-*CAC Arg-4His + + F/58
5 Codon 175 CGC-*CAC Arg--His + + F/66
5 Codon 175 CGC-4CAC Arg-*His + + F/64
5 Codon 175 CGC-*CAC Arg-+His + + F/41
5 Codon 176 TGC-TAC Cys-Tyr + + M/61
6 Codon 188 CTG-*CTG Frame shift-truncated protein (207 a.a.) - + M/74
(1-bp insertion)
6 Codon 190/191 CCT lnframe deletion - Pro + + M/83
(3-bp deletion)
6 Codon 209 AGA-)A Frame shift-truncated protein (213 a.a.) - + M/64
(2-bp deletion)
7 Codon 232 ATC-+TTC lle-*Phe - + M/62
7 Codon 234 TAC-TGC Tyr-*Cys + + M/45
7 Codon 245 GGC-*GAC Gly-4Asp + - M/67
7 Codon 245 GGC-*AGC Gly-*Ser + + F/62
7 Codon 245 GGC--AGC Gly-*Ser + + M/76
7 Codon 245 GGC-*AGC Gly-*Ser + + F/38
7 Codon 246-250 Inframe deletion of Met-Asn-Arg-Arg-Pro + + M/87
(15-bp deletion)
7 Codon 248 CGG-TGG Arg-*Trp + + F/80
7 Codon 248 CGG-*TGG Arg-*Trp + + M/66
7 Codon 248 CGG-TGG Arg-*Trp + + M/82
7 Codon 248 CGG-*CAG Arg-4Gln + + F/40
7 Codon 258 GAA-*CAA Glu-*Gln + + M/55
8 Codon 278 CCT-*TCT Pro-4Ser + + F/88
8 Codon 282 CGG-*TGG Arg-*Trp + + M/52
8 Codon 282 CGG-*TGG Arg-*Trp + + F/59
8 Codon 282 CGG-*TGG Arg-*Trp + + F/44
8 Codon 306 CGA-4TGA Arg-*Stop - + Ff70
Truncated protein (305 a.a.)
IHC, immunohistochemistry.
Table 4 A comparison of the spectrum of p53 mutations in colorectal
carcinomas of Hong Kong, Scotland (Cripps et al, 1994) and the world
database (Greenblatt et al, 1994; Hollstein et al, 1994)
Database Hong Kong Scotland
Percentage of p53mutations 50 43 46.7
G:C-*A:T(%) 63 65 86.3
G:C-4T:A(%) 9 3.4 9
G:C-C:G(%) 3 3.4 0
A:T->G:C(%) 11 6.9 0
A:T-T:A(%) 4 3.4 0
A:T-*C:G(%) 1 0 4.5
Del/Ins and others (%) 8 17.2 0
Hot spots 175,245,248,273,282 175,245,248,282 175,245,248
consideration ofthe possibility that the Hong Kong Chinese popu-
lation gene pool may be enriched in genes conferring susceptibility
to colorectal cancer. Some support for this proposition comes from
the similar high incidence of cancer in young people in other
southern Chinese communities (Singapore and Shanghai) but not
in Japanese, Northern Chinese (Tianjin) or the Caucasian popula-
tions of the USA, despite the overall high incidence of colorectal
cancer in Some of these countries.
We considered the possibility that either of these observations
might merely represent artefacts of changes in reporting practice.
Health care that is almost free ofcharge has been universally avail-
able in Hong Kong and in Scotland. The Cancer Registries had
been in full operation in Hong Kong since 1963 and in Scotland
since 1959. The data were largely gathered from in-patient
sources, and duplicated entries were prevented by checking the
demographic data. Full population census was carried out in Hong
Kong every 10 years with a by-census in betwen two full censuses.
We have also shown that the component of inappropriate diag-
noses included in the same code as colorectal cancer is trivial.
Thus, the formal basis ofreporting colorectal cancer diagnosis and
ofconducting population census is very similar in Scotland and in
Hong Kong. Moreover, the unusual nature ofthis cancer in persons
less than 35 years of age militates strongly against inaccurate
reporting in either country.
A second possible explanation of the high incidence in young
Hong Kong Chinese is a 'cohort effect', signalling the arrival
within the population of a factor preferentially affecting a younger
age group. A clear example of this would be dietary change
favoured by younger people but declined by their elders. With the
passage oftime, the effects ofthe hypothetical factor might appear
in progressively older people, as the population-at-risk ages. This
explanation is superficially attractive, as it might encompass both
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the raised incidence in young people and the rising incidence in
their elders. It is insufficient to explain the difference in age-inci-
dence patterns between Hong Kong and Scotland, however, unless
it is accepted that a new cohort, with an incidence of colorectal
cancer farexceeding that ofScotland, appeared in Hong Kong at or
before 1978. Under these circumstances, it would not be antici-
pated that the rise in incidence after 1982 should be restricted to
persons aged over 50 years. Moreover, Japan, which does show the
recent rise in overall incidence of the disease, does not share this
elevated incidence in young people, while Shanghai, which has
only a slightly rising trend, does show high incidence in the young.
Detailed analysis of mutation types in oncogenes and oncosup-
pressor genes in cancer has sometimes revealed clues to the nature
of both environmental carcinogens and constitutional suscepti-
bility (Shields and Harris, 1991). Thus, characteristic patterns in
the relative incidence oftransversion and transition mutations have
been recorded for Ki-ras and p53 in lung cancer in smokers vs
non-smokers (Suzuki et al, 1992; Husgafvel Pursiainen et al, 1993;
Takeshima et al, 1993; Yang et al, 1995). A predilection
for small insertions and deletions in simple nucleotide repeat
sequences in APC has been recorded in patients with evidence of
defects in mismatch repair (Huang et al, 1996). We therefore
searched for characteristic 'signatures' in the mutations in two
genes-Ki-ras and p53 - which we have shown to be involved in
colorectal cancer in Hong Kong with similar frequency compared
with elsewhere. No differences were observed in the mutations in
Ki-ras, but the options in this gene are restricted to the small
number of nucleotide loci involved in oncogenic transformation.
Mutations inp53 allow more variety, and here we demonstrated an
unusually high frequency ofsmall insertion and deletion mutation
- more than twice that of data combined from all currently
reported series of colorectal cancers (Table 4) (Greenblatt et al,
1994; Hollstein et al, 1994). In contrast no mutations of this type
were detected in a series of21 cases gathered by exactly analogous
methods from a Scottish population (Cripps et al, 1994). Of the
five frameshift type mutations detected in Hong Kong tumours,
two are in recognizable target sequences for mismatch repair gene
activity. The age spectrum ofthe Hong Kong and Scottish tumours
analysed for p53 mutation was identical, hence these unusual
mutations are not included merely because of a bias towards
younger patients in the Hong Kong sample.
Although these data must be regarded as suggestive only, they
encourage further search for agenetic basis forincreased colorectal
cancer susceptibility in the Hong Kong Chinese population.
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